comparemela.com
Home
Live Updates
Nuvectis Pharma, Inc. Announces a Collaboration with Mayo Clinic to Evaluate NXP800 in an Investigator-Sponsored Clinical Trial in Cholangiocarcinoma : comparemela.com
Nuvectis Pharma, Inc. Announces a Collaboration with Mayo Clinic to Evaluate NXP800 in an Investigator-Sponsored Clinical Trial in Cholangiocarcinoma
Mitesh Borad, M.D., will serve as the Principal Investigator for the clinical trialThe Investigator-sponsored clinical trial follows the robust preclinical proof of concept data generated by...
Related Keywords
United States ,
Arizona ,
American ,
Christopherm Calabrese ,
Ron Bentsur ,
Mayo Clinic Comprehensive Cancer Center ,
Nuvectis Pharma Inc ,
Exchange Commission ,
Nasdaq ,
American Association For Cancer Research ,
Company Contact ,
Mitesh Borad ,
Principal Investigator ,
Mayo Clinic ,
Cancer Research ,
Chief Executive Officer ,
Nuvectis Pharma ,
Fast Track Designation ,
Orphan Drug Designation ,
Mutated Ovarian Cancer ,
Private Securities Litigation Reform Act ,
Markets ,
comparemela.com © 2020. All Rights Reserved.